Frank Barbera

638 total citations
17 papers, 502 citations indexed

About

Frank Barbera is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Frank Barbera has authored 17 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 6 papers in Genetics and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Frank Barbera's work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Renin-Angiotensin System Studies (3 papers). Frank Barbera is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (10 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Renin-Angiotensin System Studies (3 papers). Frank Barbera collaborates with scholars based in United States, Germany and Sweden. Frank Barbera's co-authors include Dietmar Seiffert, Xinkang Wang, J. Eileen Bird, Patricia L. Smith, William F. Herblin, Stuart A. Rosenfeld, Paul L. Gunyuzlu, Michael W. Pantoliano, L D Thompson and Barry A. Springer and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Frank Barbera

16 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Barbera United States 10 197 166 156 91 86 17 502
Rene Pagila United States 5 236 1.2× 287 1.7× 59 0.4× 57 0.6× 17 0.2× 6 557
Alain Gast Switzerland 11 258 1.3× 154 0.9× 32 0.2× 6 0.1× 73 0.8× 19 558
Enrique Alvarez Sotomayor United States 7 411 2.1× 45 0.3× 38 0.2× 51 0.6× 15 0.2× 9 590
S. Sperl Germany 12 173 0.9× 185 1.1× 77 0.5× 18 0.2× 24 0.3× 15 500
Xiaofen Pan China 15 330 1.7× 141 0.8× 67 0.4× 26 0.3× 102 1.2× 35 706
Maria Nyåkern Italy 7 426 2.2× 173 1.0× 55 0.4× 40 0.4× 20 0.2× 11 585
Sanaz Maleki Australia 12 344 1.7× 29 0.2× 64 0.4× 33 0.4× 35 0.4× 15 643
Robert S. Gronke United States 10 163 0.8× 98 0.6× 44 0.3× 22 0.2× 5 0.1× 13 418
Andrea Uecker Germany 9 207 1.1× 110 0.7× 56 0.4× 26 0.3× 119 1.4× 12 457
Cristina Cellai Italy 13 309 1.6× 252 1.5× 194 1.2× 31 0.3× 23 0.3× 19 579

Countries citing papers authored by Frank Barbera

Since Specialization
Citations

This map shows the geographic impact of Frank Barbera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Barbera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Barbera more than expected).

Fields of papers citing papers by Frank Barbera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Barbera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Barbera. The network helps show where Frank Barbera may publish in the future.

Co-authorship network of co-authors of Frank Barbera

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Barbera. A scholar is included among the top collaborators of Frank Barbera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Barbera. Frank Barbera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Corte, James R., Tianan Fang, Jon J. Hangeland, et al.. (2014). Pyridine and pyridinone-based factor XIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(4). 925–930. 14 indexed citations
2.
Quan, Mimi L., Pancras C. Wong, Francis J. Woerner, et al.. (2014). Tetrahydroquinoline Derivatives as Potent and Selective Factor XIa Inhibitors. Journal of Medicinal Chemistry. 57(3). 955–969. 62 indexed citations
3.
Zhang, Xiaojun, Peter W. Glunz, Wen Jiang, et al.. (2013). Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF–FVIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(6). 1604–1607. 7 indexed citations
4.
Bird, J. Eileen, et al.. (2012). A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis. Journal of Thrombosis and Thrombolysis. 34(2). 199–207. 23 indexed citations
5.
Bird, J. Eileen, Patricia L. Smith, Xinkang Wang, et al.. (2012). Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: Murine Ortholog of the Fletcher Trait. Thrombosis and Haemostasis. 107(6). 1141–1150. 36 indexed citations
6.
Bird, J. Eileen, Patricia L. Smith, Xinkang Wang, et al.. (2012). Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: Murine Ortholog of the Fletcher Trait. Thrombosis and Haemostasis. 107(6). 1141–1150. 68 indexed citations
7.
Bird, J. Eileen, Mary R. Giancarli, Frank Barbera, et al.. (2008). Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis. Thrombosis Research. 123(1). 146–158. 9 indexed citations
8.
Luettgen, Joseph M., Jeffrey M. Bozarth, Frank Barbera, et al.. (2006). In Vitro Evaluation of Apixaban, a Novel, Potent, Selective and Orally Bioavailable Factor Xa Inhibitor.. Blood. 108(11). 4130–4130. 25 indexed citations
9.
Smallheer, Joanne M., Richard Alexander, Jianmin Wang, et al.. (2004). SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and Xa. Bioorganic & Medicinal Chemistry Letters. 14(21). 5263–5267. 30 indexed citations
10.
Wang, Xinkang, Robert T. Dorsam, Adam Lauver, et al.. (2002). Comparative Analysis of Various Platelet Glycoprotein IIb/IIIa Antagonists on Shear-Induced Platelet Activation and Adhesion. Journal of Pharmacology and Experimental Therapeutics. 303(3). 1114–1120. 22 indexed citations
11.
Batt, Douglas G., Joseph J. Petraitis, Gary A. Cain, et al.. (1999). Disubstituted Indazoles as Potent Antagonists of the Integrin αvβ3. Journal of Medicinal Chemistry. 43(1). 41–58. 63 indexed citations
12.
Seiffert, Dietmar, et al.. (1999). Prothrombin Activation in Rabbits. Thrombosis Research. 93(3). 101–112. 5 indexed citations
13.
Herblin, William F., et al.. (1998). A novel angiotensin II binding site in murine tissues. Life Sciences. 63(3). 223–234. 1 indexed citations
14.
Herblin, William F. & Frank Barbera. (1995). A rapid, high capacity assay for basic fibroblast growth factor binding. Life Sciences. 56(15). 1257–1264. 2 indexed citations
15.
Springer, Barry A., Michael W. Pantoliano, Frank Barbera, et al.. (1994). Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis.. Journal of Biological Chemistry. 269(43). 26879–26884. 127 indexed citations
16.
Mazzone, G, Rosario Pignatello, Anna Maria Panico, et al.. (1992). Synthesis of carboxyalkylthio-triazoles and bicyclic derivatives with antiinflammatory and analgesic activity.. PubMed. 47(2). 149–69. 6 indexed citations
17.
Barbera, Frank, et al.. (1967). FACTORS IN ACUTE HYPOTENSION AND VENTRICULAR FIBRILLATION AFTER CARDIAC NECROSIS. The American Journal of the Medical Sciences. 253(6). 675–675. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026